Sayumi Yamazoe
Company: Bristol Myers Squibb
Job title: Senior Principal Scientist
Seminars:
Highlighting How the Mode of Conjugation Impacts Challenges During Bioconjugation & Resulting ADC Behavior 1:30 pm
Honing conjugation chemistries concerning the mAb to develop and advance conjugation technologies Understanding the relationship between ADC design and thermal and chemical/ metabolic stability Analyzing how to align linker and conjugation chemistries with each payload propertyRead more
day: Scientific Program Day 2
Delving Into Site-Specific Conjugations to Create Homogenous ADCs 1:01 pm
In the last two years, the proportion of clinically site-specific ADC has increased from 23% to 29%*, and novel site-specific conjugation technologies have overtaken traditional cysteine-based site-specific ADCs. This has given food for thought to ADC developers on what conjugation strategies to employ. It has also made assessing the advantages of site-specific conjugation versus stochastic…Read more
day: Pre-Conference Workshop Day